|Description||TDI-4161 is a novel alphaVbeta3 antagonist developed for osteoporosis therapy. It inhibits alphaVbeta3-dependent cell adhesion without inducing high-affinity ligand binding or exposure of the epitope for MAb AP5 (both dependent on the beta3 PSI domain).|
|Brife Description||alphaVbeta3 antagonist, osteoporosis therapy|
|Synonyms||TDI-4161; TDI 4161; TDI4161|
|Application||potential osteoporosis therapy|
|Current Developer||Rockefeller University|
Mulberroside A, extracted from the root bark of white mulberry, could reduce P-gp expression and function being along with the activation of PKC and NF-κB. It h...
GI-181771X is a novel effect of oral CCK-1 agonist on fasting and postprandial gastric functions in healthy volunteers.
(S)-3-aminotetrahydrothiophene 1,1-dioxide hydrochloride is an important sulfur-containing heterocyclic compounds. It is widely used as building blocks in many ...
Quizalofop-P-ethyl, a quinoxaline derivative, is a sort of post-emergence herbicide that might be effective in regulating annual and perennial grass weeds.
J 147, under the IUPAC name N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N-[(E)-(3-methoxyphenyl)methylideneamino]acetamide, a phenyl hydrazide compound that has been...
AR 244555 is an inverse agonist of Mas G-protein signaling (IC50 values 186 and 348 nM in human and rat inositol phosphatase (IP) Gq coupling assays respectivel...
Cyanidin-3-O-glucoside is a anthocyanin that is naturally occurring in various fruits, vegetable and plants that exert a protective effect against endothelial d...
Nanterinone mesylate is the methyl sulfonate form of Nanterinone, which is a novel positive inotropic and balanced-type vasodilating drug partially based on pho...